The current ZNTL market cap is 921.06M. The company's latest EPS is USD -4.1177 and P/E is -3.15.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -54.19M | -68.04M | -67.26M | -117.62M | -57.77M |
Net Income | -54.4M | -54.97M | -63.22M | -112.53M | -55.53M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -46.85M | -118.79M | -209.57M | -243.57M | -315.52M |
Net Income | -45.66M | -117.84M | -158.73M | -236.81M | -292.19M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 529.19M | 539.31M | 489.34M | 621.44M | 585.72M |
Total Liabilities | 100.46M | 105.29M | 103.68M | 98.16M | 103.82M |
Total Equity | 428.74M | 434.02M | 385.67M | 523.28M | 481.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 87.48M | 365.56M | 454.51M | 539.31M | 551.69M |
Total Liabilities | 19.06M | 32.18M | 90.03M | 105.29M | 114.3M |
Total Equity | -73.29M | 333.38M | 364.48M | 434.02M | 437.39M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -126.42M | -163.75M | -49.28M | -128.56M | -167.22M |
Investing | -102.29M | -114.18M | 42.12M | 115.05M | -2.4M |
Financing | 211.3M | 261.04M | 373k | 236.99M | 237.3M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -39.14M | -86.83M | -154.09M | -163.75M | -207.82M |
Investing | -352k | -284.83M | -18.12M | -114.18M | -44.46M |
Financing | 81.83M | 360.44M | 178.52M | 261.04M | 237.3M |
Market Cap | 921.06M |
Price to Earnings Ratio | -3.15 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 32.83 |
Price to Book Ratio | 2.1 |
Dividend Yield | - |
Shares Outstanding | 70.96M |
Average Volume (1 week) | 668.04k |
Average Volume (1 Month) | 687.12k |
52 Week Change | -38.07% |
52 Week High | 31.46 |
52 Week Low | 9.56 |
Spread (Intraday) | 0.02 (0.15%) |
Company Name | Zentalis Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.zentalis.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.